studies used supplementation with DHA (docosahexaenoic acid) and EPA (eicosapentaenoic acid), precursors of anti-inflammatory eicosanoids previously shown to reduce CRP in subjects presenting with dyslipidaemia or higher baseline inflammatory status, as synthetized in Guo’s meta-analysis (52). Here, CRP is linked to inherited lipid metabolism disorder.